LabBook, Inc. Licenses XML-Life Sciences Genomic Information Solution to Celestar Lexico-Sciences, Inc.

Celestar Lexico is a Biotech Venture of Daiichi

Pharmaceutical and Fujitsu



Apr 18, 2001, 01:00 ET from LabBook, Inc.

    MCLEAN, Va., and COLUMBUS, Ohio, April 18 /PRNewswire/ -- LabBook, Inc.,
 today announced that it has signed a non-exclusive license agreement with
 Celestar Lexico-Sciences, Inc. a biotech-venture of Daiichi and Fujitsu in
 Japan, to provide its XML-Life Sciences Genomics Solution. The LabBook
 Genomics solution allows Celestar Lexico-Sciences direct access to the Ohio
 State University (OSU) Human Genome Database and utilizes LabBook's
 proprietary Genomic XML Browser and Query Search engine. The OSU Human Genome
 Database is fully integrated and annotated, and is offered exclusively by
 LabBook at http://www.labbook.com .
     Celestar Lexico-Sciences (CLS) was created with core technologies in
 bioinformatics. Daiichi Pharmaceutical Co., Ltd. of Japan and CLS recently
 initiated a 5-year collaborative research program in genomics-based drug
 discovery. The collaboration will tap into CLS's proprietary protein
 prediction algorithms. Fujitsu Limited, which owns 20% of CLS, will fully
 support these efforts with its own intellectual properties and methodologies.
 Celestar researchers will use LabBook's Genomic XML Browser(TM) and Query
 search engine to mine the Human Genome database with the goal of identifying
 lead compounds that will act on disease-related genes resulting in better
 treatment options for patients.
     Dr. Hirofumi Doi, President and CEO, of Celestar Lexico-Sciences, Inc.
 commented on the license agreement with LabBook:  "The XML-Genomic Browser
 from LabBook, Inc. is an elegant and powerful bioinformatics tool that will
 enable significant advances in drug discovery. Central to the elucidation of
 genomic functions and identification of gene properties that result in certain
 diseases, is the expanding role of emerging bioinformatics technologies. These
 technologies are required to simultaneously access multiple large databases
 and to rapidly integrate data in useful forms. We are extremely pleased to be
 using LabBook's XML solutions to assist Celestar Lexico-Sciences's research
 efforts."
     About eLabBook(TM), XML-Genomic Browser(TM), and OSU Human Genome Database
     Celestar Lexico-Sciences will be integrating its drug discovery programs
 using the LabBook Genomic Suite, which includes the eLabBook, the Genomic XML
 Browser(TM), and the Genome Database and Query System.
     eLabBook is a research  information and project management tool that
 integrates local data and documents with web-based research through a
 'discovery desktop' that provides contextual access to scientific tools,
 content and services. The eLabBook includes the Librarian, which provides
 storage, retrieval, and searching of all the diverse collections of research
 documents and data.
     Genomic XML Browser(TM): a powerful graphic interface for visualizing and
 accessing genomic information in meaningful and interactive ways, built around
 the industry standard XML data format (BSML) developed by LabBook. Combining
 BSML with an interactive, easy-to-use Browser creates the ideal "front end"
 for bioinformatics. This solution enables dynamic integration and annotation
 of diverse data. The Genomic XML Browser(TM) is part of LabBook's information
 layer for discovery that includes XML-aware tools for management, analysis,
 and communication of research data in the life sciences.
     The OSU human genome database is based on the compilation and integration
 of multiple independent maps including UniGene, dbEST, and the draft human
 genome sequence, and the gene index is based on assembled and mapped
 transcripts rather than gene prediction.  This accurate map is coupled with an
 hypothesis-driven interface that allows users to query the richly annotated
 database in a meaningful fashion and deliver results in an interactive visual
 environment. This database will serve as a framework for organizing
 proprietary genomic data, and LabBook's XML converters will integrate multiple
 research databases to accelerate implementation of Celestar Lexico-Sciences'
 novel drug discovery strategies.
     About LabBook Inc.
     LabBook, Inc. is an XML-based life science informatics provider for the
 biotechnology, pharmaceutical, and academic life science researcher.  LabBook
 will accelerate the drug discovery process by providing enabling software
 solutions and targeted-information and services to the scientific community.
 LabBook, Inc. offices are located in McLean, Virginia and Columbus, Ohio.  To
 learn more contact us at http://www.labbook.com .
 
     Certain statements contained in this release may be forward looking
 statements and are thus prospective. Such forward-looking statements are
 subject to risks, uncertainties and other factors which could cause actual
 results to differ materially from future results expressed or implied by such
 forward looking statements.
 
 

SOURCE LabBook, Inc.
    MCLEAN, Va., and COLUMBUS, Ohio, April 18 /PRNewswire/ -- LabBook, Inc.,
 today announced that it has signed a non-exclusive license agreement with
 Celestar Lexico-Sciences, Inc. a biotech-venture of Daiichi and Fujitsu in
 Japan, to provide its XML-Life Sciences Genomics Solution. The LabBook
 Genomics solution allows Celestar Lexico-Sciences direct access to the Ohio
 State University (OSU) Human Genome Database and utilizes LabBook's
 proprietary Genomic XML Browser and Query Search engine. The OSU Human Genome
 Database is fully integrated and annotated, and is offered exclusively by
 LabBook at http://www.labbook.com .
     Celestar Lexico-Sciences (CLS) was created with core technologies in
 bioinformatics. Daiichi Pharmaceutical Co., Ltd. of Japan and CLS recently
 initiated a 5-year collaborative research program in genomics-based drug
 discovery. The collaboration will tap into CLS's proprietary protein
 prediction algorithms. Fujitsu Limited, which owns 20% of CLS, will fully
 support these efforts with its own intellectual properties and methodologies.
 Celestar researchers will use LabBook's Genomic XML Browser(TM) and Query
 search engine to mine the Human Genome database with the goal of identifying
 lead compounds that will act on disease-related genes resulting in better
 treatment options for patients.
     Dr. Hirofumi Doi, President and CEO, of Celestar Lexico-Sciences, Inc.
 commented on the license agreement with LabBook:  "The XML-Genomic Browser
 from LabBook, Inc. is an elegant and powerful bioinformatics tool that will
 enable significant advances in drug discovery. Central to the elucidation of
 genomic functions and identification of gene properties that result in certain
 diseases, is the expanding role of emerging bioinformatics technologies. These
 technologies are required to simultaneously access multiple large databases
 and to rapidly integrate data in useful forms. We are extremely pleased to be
 using LabBook's XML solutions to assist Celestar Lexico-Sciences's research
 efforts."
     About eLabBook(TM), XML-Genomic Browser(TM), and OSU Human Genome Database
     Celestar Lexico-Sciences will be integrating its drug discovery programs
 using the LabBook Genomic Suite, which includes the eLabBook, the Genomic XML
 Browser(TM), and the Genome Database and Query System.
     eLabBook is a research  information and project management tool that
 integrates local data and documents with web-based research through a
 'discovery desktop' that provides contextual access to scientific tools,
 content and services. The eLabBook includes the Librarian, which provides
 storage, retrieval, and searching of all the diverse collections of research
 documents and data.
     Genomic XML Browser(TM): a powerful graphic interface for visualizing and
 accessing genomic information in meaningful and interactive ways, built around
 the industry standard XML data format (BSML) developed by LabBook. Combining
 BSML with an interactive, easy-to-use Browser creates the ideal "front end"
 for bioinformatics. This solution enables dynamic integration and annotation
 of diverse data. The Genomic XML Browser(TM) is part of LabBook's information
 layer for discovery that includes XML-aware tools for management, analysis,
 and communication of research data in the life sciences.
     The OSU human genome database is based on the compilation and integration
 of multiple independent maps including UniGene, dbEST, and the draft human
 genome sequence, and the gene index is based on assembled and mapped
 transcripts rather than gene prediction.  This accurate map is coupled with an
 hypothesis-driven interface that allows users to query the richly annotated
 database in a meaningful fashion and deliver results in an interactive visual
 environment. This database will serve as a framework for organizing
 proprietary genomic data, and LabBook's XML converters will integrate multiple
 research databases to accelerate implementation of Celestar Lexico-Sciences'
 novel drug discovery strategies.
     About LabBook Inc.
     LabBook, Inc. is an XML-based life science informatics provider for the
 biotechnology, pharmaceutical, and academic life science researcher.  LabBook
 will accelerate the drug discovery process by providing enabling software
 solutions and targeted-information and services to the scientific community.
 LabBook, Inc. offices are located in McLean, Virginia and Columbus, Ohio.  To
 learn more contact us at http://www.labbook.com .
 
     Certain statements contained in this release may be forward looking
 statements and are thus prospective. Such forward-looking statements are
 subject to risks, uncertainties and other factors which could cause actual
 results to differ materially from future results expressed or implied by such
 forward looking statements.
 
 SOURCE  LabBook, Inc.